{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/11/3343136/0/en/belite-bio-announces-u-s-food-and-drug-administration-acceptance-and-priority-review-of-new-drug-application-for-tinlarebant-for-the-treatment-of-stargardt-disease-type-1.html", "message": "News view counter 876168 successfully enlarged"}